Takeda Pharmaceutical Co Stock Analysis

Takeda Stock Analysis Notes

The company has price-to-book ratio of 0.94. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Takeda Pharmaceutical has Price/Earnings To Growth (PEG) ratio of 0.7. The entity last dividend was issued on the 27th of March 2024. Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan. Takeda Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 47347 people. To find out more about Takeda Pharmaceutical Co contact Christophe Weber at 81 3 3278-2111 or learn more at https://www.takeda.com.

Takeda Pharmaceutical Investment Alerts

Takeda Pharmaceutical Upcoming and Recent Events

Takeda Largest EPS Surprises

View All Earnings Estimates

Takeda Pharmaceutical Environmental, Social, and Governance (ESG) Scores

Takeda Stock Institutional Investors

Note, although Takeda Pharmaceutical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Takeda Market Capitalization

The company currently falls under 'Large-Cap' category with a total capitalization of 43.18 B.

Takeda Profitablity

The company has Net Profit Margin of 0.06 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.21 %, which entails that for every 100 dollars of revenue, it generated $0.21 of operating income.

Management Efficiency

Takeda Pharmaceutical has Return on Asset of 0.0278 % which means that on every $100 spent on assets, it made $0.0278 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0415 %, implying that it generated $0.0415 on every 100 dollars invested. Takeda Pharmaceutical's management efficiency ratios could be used to measure how well Takeda Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to 0.03. The value of Return On Capital Employed is expected to slide to 0.02. At this time, Takeda Pharmaceutical's Total Current Liabilities is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 15.9 T this year, although the value of Non Current Liabilities Other will most likely fall to about 435.2 B.

Technical Drivers

As of the 30th of November, Takeda Pharmaceutical has the Risk Adjusted Performance of (0.09), coefficient of variation of (841.23), and Variance of 0.7728. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Takeda Pharmaceutical, as well as the relationship between them.

Takeda Pharmaceutical Price Movement Analysis

Takeda Pharmaceutical Outstanding Bonds

Takeda Pharmaceutical Predictive Daily Indicators

Takeda Pharmaceutical Corporate Filings

Takeda Pharmaceutical Forecast Models

Takeda Pharmaceutical's time-series forecasting models are one of many Takeda Pharmaceutical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Takeda Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Takeda Pharmaceutical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Takeda shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Takeda Pharmaceutical. By using and applying Takeda Stock analysis, traders can create a robust methodology for identifying Takeda entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Takeda analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Takeda analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Takeda Pharmaceutical Co stock analysis indicators help investors evaluate how Takeda Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Takeda Pharmaceutical shares will generate the highest return on investment. By understating and applying Takeda Pharmaceutical stock analysis, traders can identify Takeda Pharmaceutical position entry and exit signals to maximize returns.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Takeda Pharmaceutical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Takeda Pharmaceutical. If investors know Takeda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Takeda Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Takeda Pharmaceutical is measured differently than its book value, which is the value of Takeda that is recorded on the company's balance sheet. Investors also form their own opinion of Takeda Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Takeda Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Takeda Pharmaceutical's market value can be influenced by many factors that don't directly affect Takeda Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Takeda Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Takeda Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Takeda Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.